Research ExplorerScientific StaffBarbara Schmalfeldt Publications

Prof.Dr.med. ID: 2373005

Barbara Schmalfeldt

graph of relations
Affiliations
151 - 193 out of 193Page size: 50

Publications

  1. 2008

  2. Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO

    Oskay-Oezcelik, G., Koensgen, D., Hindenburg, H-J., Klare, P., Schmalfeldt, B., Lichtenegger, W., Chekerov, R., Al-Batran, S-E., Neumann, U., Sehouli, J. & Ovarian Cancer Study Group of the North-Eastern Germany Society of Gynecological Oncology (NOGGO), 29.05.2008, In: ANTICANCER RES. 28, 2B, p. 1329-34 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients

    Blechschmidt, K., Sassen, S., Schmalfeldt, B., Schuster, T., Höfler, H. & Becker, K-F., 29.01.2008, In: BRIT J CANCER. 98, 2, p. 489-95 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Present and future developments in the diagnosis and treatment of ovarian cancer.

    Schmalfeldt, B., 2008, In: GEBURTSH FRAUENHEILK. 68, 4, p. 382-88

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2007

  6. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients

    Röper, B., Astner, S. T., Heydemann-Obradovic, A., Thamm, R., Jacob, V., Hölzel, D., Schmalfeldt, B., Kiechle-Bahat, M., Höss, C. & Molls, M., 12.2007, In: GYNECOL ONCOL. 107, 3, p. 541-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study

    Burges, A., Wimberger, P., Kümper, C., Gorbounova, V., Sommer, H., Schmalfeldt, B., Pfisterer, J., Lichinitser, M., Makhson, A., Moiseyenko, V., Lahr, A., Schulze, E., Jäger, M., Ströhlein, M. A., Heiss, M. M., Gottwald, T., Lindhofer, H. & Kimmig, R., 01.07.2007, In: CLIN CANCER RES. 13, 13, p. 3899-905 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer

    Sassen, S., Schmalfeldt, B., Avril, N., Kuhn, W., Busch, R., Höfler, H., Fend, F. & Nährig, J., 06.2007, In: HUM PATHOL. 38, 6, p. 926-34 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)

    Wagner, U., du Bois, A., Pfisterer, J., Huober, J., Loibl, S., Lück, H-J., Sehouli, J., Gropp, M., Stähle, A., Schmalfeldt, B., Meier, W., Jackisch, C. & AGO Ovarian Cancer Study Group, 04.2007, In: GYNECOL ONCOL. 105, 1, p. 132-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients

    Dorn, J., Schmitt, M., Kates, R., Schmalfeldt, B., Kiechle, M., Scorilas, A., Diamandis, E. P. & Harbeck, N., 15.03.2007, In: CLIN CANCER RES. 13, 6, p. 1742-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Diagnostik und Therapie maligner Ovarialtumoren

    Schmalfeldt, B., 2007, In: Frauenarzt. 48, 11, p. 1054-57

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Interdisziplinäre S2k-Leitlinie für die Diagnostik und Therapie maligner Ovarialtumoren.

    Schmalfeldt, B. & Pfisterer, J., 2007, Manual Mammakarzinom. : Empfehlungen zu Diagnostik, Therapie und Nachsorge. . Janni, W. (ed.). 11 ed. München Wien New York : W. Zuckschwerdt Verlag

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Transfer

  13. Operative treatment of ovarian cancer.

    Schmalfeldt, B., 2007, In: GEBURTSH FRAUENHEILK. 67, 6, p. 14-19

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2006

  15. Akute Ovarialvenenthrombose im dritten Trimenon

    Rattenhuber, J., Schmalfeldt, B., Fischer, T. & Schneider, K. T., 12.2006, In: Zentralblatt für Gynäkologie. 128, 6, p. 366-8 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  16. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

    Harter, P., du Bois, A., Hahmann, M., Hasenburg, A., Burges, A., Loibl, S., Gropp, M., Huober, J., Fink, D., Schröder, W., Muenstedt, K., Schmalfeldt, B., Emons, G., Pfisterer, J., Wollschlaeger, K., Meerpohl, H-G., Breitbach, G-P., Tanner, B., Sehouli, J. & Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee, 12.2006, In: ANN SURG ONCOL. 13, 12, p. 1702-10 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?

    du Bois, A., Schmalfeldt, B., Meier, W., Sehouli, J., Pfisterer, J. & Arbeitsgemeinschaft Gynaekologische Onkologie [AGO] Kommission OVAR, 03.10.2006, In: INT J GYNECOL CANCER. 16, 5, p. 1756-60 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma

    Dorn, J., Harbeck, N., Kates, R., Magdolen, V., Grass, L., Soosaipillai, A., Schmalfeldt, B., Diamandis, E. P. & Schmitt, M., 08.2006, In: BIOL CHEM. 387, 8, p. 1121-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Ovarialkarzinom -- ist die intraperitoneale Therapie wirklich neuer Standard?

    du Bois, A., Schmalfeldt, B., Meier, W., Sehouli, J. & Pfisterer, J., 08.2006, In: Zentralblatt für Gynäkologie. 128, 4, p. 202-6 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer:results of a multicenter phase-II trial

    Sehouli, J., Oskay-Ozcelik, G., Kühne, J., Stengel, D., Hindenburg, H-J., Klare, P., Heinrich, G., Schmalfeldt, B., Mertens, H., Camara, O., Lichtenegger, W. & Ovarian Cancer Study Group of the North-Eastern Germany Society of Gynecological Oncology (NOGGO), 06.2006, In: ANN ONCOL. 17, 6, p. 957-61 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer

    Borgoño, C. A., Kishi, T., Scorilas, A., Harbeck, N., Dorn, J., Schmalfeldt, B., Schmitt, M. & Diamandis, E. P., 01.03.2006, In: CLIN CANCER RES. 12, 5, p. 1487-93 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Diagnostik und Therapie maligner Ovarialtumoren 2005: Die Empfehlungen der Kommission Ovar der AGO

    Schmalfeldt, B., du Bois, A., Burges, A., Emons, G., Fink, D., Gropp, M., Hasenburg, A., Jäger, W., Kimmig, R., Kiechle, M., Kommoss, F., Kreienberg, R., Kuhn, W., Lück, H-J., Meier, W., Münstedt, K., Ortmann, O., Pfisterer, J., Richter, B., Runnebaum, I., Schröder, W., Sehouli, J., Tanner, B., Wagner, U. & Weis, J., 02.2006, In: Zentralblatt für Gynäkologie. 128, 1, p. 11-7 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic Tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)

    du Bois, A., Burges, A., Meier, W., Pfisterer, J., Schmalfeldt, B., Richter, B., Jackisch, C., Staehle, A., Kimmig, R., Elser, G. & Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom, 01.2006, In: ANN ONCOL. 17, 1, p. 93-6 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2005

  25. Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine

    Fischer, T., Neumayer, H-H., Fischer, R., Barenbrock, M., Schobel, H. P., Lattrell, B. C., Jacobs, V. R., Paepke, S., von Steinburg, S. P., Schmalfeldt, B., Schneider, K. T. M. & Budde, K., 11.2005, In: AM J TRANSPLANT. 5, 11, p. 2732-9 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Non-enrolment of ovarian cancer patients in clinical Trials: reasons and background

    Harter, P., du Bois, A., Schade-Brittinger, C., Burges, A., Wollschlaeger, K., Gropp, M., Schmalfeldt, B., Huober, J., Staehle, A. & Pfisterer, J., 11.2005, In: ANN ONCOL. 16, 11, p. 1801-5 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer

    Avril, N., Sassen, S., Schmalfeldt, B., Naehrig, J., Rutke, S., Weber, W. A., Werner, M., Graeff, H., Schwaiger, M. & Kuhn, W., 20.10.2005, In: J CLIN ONCOL. 23, 30, p. 7445-53 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Development of a thinner and more flexible type of minihysteroscope with a controlled 90-degree bendable tip for vision-guided endometrium biopsy

    Jacobs, V. R., Paepke, S., Schwarz-Boeger, U., Fischer, T., Pildner von Steinburg, S., Plattner, B., Schmalfeldt, B., Schaaf, H. & Kiechle, M., 11.10.2005, In: J MINIM INVAS GYN. 12, 5, p. 426-31 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8)

    du Bois, A., Belau, A., Wagner, U., Pfisterer, J., Schmalfeldt, B., Richter, B., Staehle, A., Jackisch, C., Lueck, H. J., Schroeder, W., Burges, A., Olbricht, S., Elser, G. & Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR), 02.2005, In: GYNECOL ONCOL. 96, 2, p. 444-51 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 2004

  31. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis

    Diamandis, E. P., Borgoño, C. A., Scorilas, A., Yousef, G. M., Harbeck, N., Dorn, J., Schmalfeldt, B. & Schmitt, M., 09.03.2004, In: TUMOR BIOL. 24, 6, p. 299-309 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker

    Scorilas, A., Borgoño, C. A., Harbeck, N., Dorn, J., Schmalfeldt, B., Schmitt, M. & Diamandis, E. P., 15.02.2004, In: J CLIN ONCOL. 22, 4, p. 678-85 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. 2003

  34. Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients

    Hantke, B., Harbeck, N., Schmalfeldt, B., Claes, I., Hiller, O., Luther, M-O., Welk, A., Kuhn, W., Schmitt, M., Tschesche, H. & Muehlenweg, B., 08.2003, In: BIOL CHEM. 384, 8, p. 1247-51 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer

    Yousef, G. M., Polymeris, M-E., Grass, L., Soosaipillai, A., Chan, P-C., Scorilas, A., Borgoño, C., Harbeck, N., Schmalfeldt, B., Dorn, J., Schmitt, M. & Diamandis, E. P., 15.07.2003, In: CANCER RES. 63, 14, p. 3958-65 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Human kallikrein 8, a novel biomarker for ovarian carcinoma

    Kishi, T., Grass, L., Soosaipillai, A., Scorilas, A., Harbeck, N., Schmalfeldt, B., Dorn, J., Mysliwiec, M., Schmitt, M. & Diamandis, E. P., 01.06.2003, In: CANCER RES. 63, 11, p. 2771-4 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. 2001

  38. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma

    Kuhn, W., Rutke, S., Späthe, K., Schmalfeldt, B., Florack, G., von Hundelshausen, B., Pachyn, D., Ulm, K. & Graeff, H., 15.11.2001, In: CANCER-AM CANCER SOC. 92, 10, p. 2585-91 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer

    Lengyel, E., Schmalfeldt, B., Konik, E., Späthe, K., Härting, K., Fenn, A., Berger, U., Fridman, R., Schmitt, M., Prechtel, D. & Kuhn, W., 08.2001, In: GYNECOL ONCOL. 82, 2, p. 291-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer

    Schmalfeldt, B., Prechtel, D., Härting, K., Späthe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W. & Lengyel, E., 08.2001, In: CLIN CANCER RES. 7, 8, p. 2396-404 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 2000

  42. Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential

    Mueller, J., Brebeck, B., Schmalfeldt, B., Kuhn, W., Graeff, H. & Höfler, H., 12.2000, In: VIRCHOWS ARCH. 437, 6, p. 618-24 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. 1999

  44. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

    Kuhn, W., Schmalfeldt, B., Reuning, U., Pache, L., Berger, U., Ulm, K., Harbeck, N., Späthe, K., Dettmar, P., Höfler, H., Jänicke, F., Schmitt, M. & Graeff, H., 04.1999, In: BRIT J CANCER. 79, 11-12, p. 1746-51 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 1998

  46. Disease-adapted relapse therapy for ovarian cancer: results of a prospective study

    Kuhn, W., Schmalfeldt, B., Pache, L., Späthe, K., Ulm, K., Renziehausen, K., Nöschel, H., Canzler, E., Richter, B., Kroner, M., Tilch, G., Janicke, F. & Graeff, H., 07.1998, In: INT J ONCOL. 13, 1, p. 57-63 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. 1997

  48. Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer

    Türkmen, B., Schmitt, M., Schmalfeldt, B., Trommler, P., Hell, W., Creutzburg, S., Graeff, H. & Magdolen, V., 05.1997, In: ELECTROPHORESIS. 18, 5, p. 686-9 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. 1996

  50. Die intravenöse oder orale Etoposid-Therapie des Platin-refraktären Ovarialkarzinom-Frührezidivs. Ergebnisse einer prospektiven randomisierlen Studie

    Kuhn, W., Schmalfeldt, B., Dose, J., Pache, L., Ulm, K., Freitag, K., Jänicke, F. & Graeff, H., 02.1996, In: GEBURTSH FRAUENHEILK. 56, 2, p. 105-10 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. 1995

  52. Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2

    Schmalfeldt, B., Kuhn, W., Reuning, U., Pache, L., Dettmar, P., Schmitt, M., Jänicke, F., Höfler, H. & Graeff, H., 15.09.1995, In: CANCER RES. 55, 18, p. 3958-63 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Die septische Ovarialvenenthrombose (POVT). Konservatives Management mit CT-geführter Verlaufskontrolle

    Kuhn, W., Schmalfeldt, B., Lenz, M. & Loos, W., 05.1995, In: GEBURTSH FRAUENHEILK. 55, 5, p. 287-9 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 1994

  55. Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

    Kuhn, W., Pache, L., Schmalfeldt, B., Dettmar, P., Schmitt, M., Jänicke, F. & Graeff, H., 12.1994, In: GYNECOL ONCOL. 55, 3 Pt 1, p. 401-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Blutbedarf in der operativen Gynäkologie. Strategien zur Vermeidung von Fremdblut

    Loos, W., Kuhn, W., Prechtl, A., Schmalfeldt, B., Hipp, R. & Kycia, J., 20.10.1994, In: Fortschr Med. 112, 29, p. 405-9 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. 1993

  58. Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO III

    Kuhn, W., Jänicke, F., Pache, L., Hölscher, M., Schattenmann, G., Schmalfeldt, B., Anderl, H., Schüle, G., Dettmar, P. & Siewert, J. R., 05.1993, In: GEBURTSH FRAUENHEILK. 53, 5, p. 293-302 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next